Leadership: Page 22
-
Innovation Financing, Venture Capital, and more
For smaller companies, the ability to find funding and form alliances is the key to continuing research on innovative new medicines. For other companies, venture capital plays a huge role in financing. But some companies are also looking at alternative ways to fund their research, including publi...
By PharmaVoice Team • April 1, 2016 -
Talent Pool
Biopharma pool Mark Alles Dr. Jacqualyn Fouse Bob Hugin Scott Smith Celgene Strengthens Leadership Team Celgene has made several organizational changes to strengthen its leadership team and position the company for long-term growth. Mark Alles has been promoted to CEO. Mr. Alles is a three-decade...
By PharmaVoice Team • March 1, 2016 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Last Word
Addressing the Gender Gap Laurie Cooke, CEO of the Healthcare Businesswomen’s Association, talks about the importance of gender diversity and the HBA’s role in moving the needle. PV: The HBA recently updated its mission to include addressing the gender gap that exists within the executive leaders...
By Laurie Cooke • March 1, 2016 -
SHOWCASE FEATURE: Talent Optimization
According to PwC’s 2015 US CEO survey, CEOs say they want a workforce that reflects an increasingly diverse customer base that’s more global and tech-savvy. They are also creating new models to pave a new path forward. They are using data-supported talent strategies; fostering innovation-friendly...
By Taren Grom • March 1, 2016 -
Talent Pool
Pharma pool Paris Panayiotopoulos Ariad Names President and CEO Paris Panayiotopoulos has been appointed president and CEO of Ariad, an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. Most recently, Mr. Panayiotopoulos was presi...
By PharmaVoice Team • Feb. 1, 2016 -
Talent Pool
Pharma pool Paul Biondi Bristol-Myers Squibb Appoints Senior VP, Head of Business Development Bristol-Myers Squibb has appointed Paul Biondi as senior VP, head of business development. In this role, he is responsible for leading the development of strategic partnerships and pursuing scientific in...
By PharmaVoice Team • Jan. 1, 2016 -
Talent Pool
Pharma pool Dr. James Bradner Novartis Institutes for BioMedical Research Appoints President Dr. James (Jay) Bradner, physician-scientist from Dana-Farber Cancer Institute and Harvard Medical School, has been appointed president of the Novartis Institutes for BioMedical Research (NIBR) and a memb...
By PharmaVoice Team • Nov. 15, 2015 -
Reputation: Solving the Reputation Challenge
There is no denying that the pharmaceutical industry has a problem. The industry continues to field questions about its pricing, off-label prescribing, and salesforce practices. These forces culminated this fall when Turing CEO Martin Shkreli — dubbed the most hated man in America at the time — r...
By Denise Myshko • Nov. 15, 2015 -
Talent Pool
Pharma Pool Susan Benton Tracey Dawson Shire Appoints New Executive Team Leads Susan Benton, an industry veteran with more than 25 years of commercial business experience, including 17 years focused in ophthalmology, has been named head of business development, ophthalmics, Shire. She is responsi...
By PharmaVoice Team • Oct. 1, 2015 -
Talent Pool
Biotech Pool Dr. Nathalie Adda Enanta Names Chief Medical Officer Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has appointed Nathalie Adda, M.D., as senior VP and chief medical ...
By PharmaVoice Team • Sept. 1, 2015 -
Letter from the Editor
Celebrating Inspiration When we first conceptualized this special issue 11 years ago, the idea was that it would be nice to showcase the people who are having a positive impact on the industry. We didn’t know then that this issue would come to mean so much more than a metaphoric high five. Over t...
By Taren Grom • Aug. 1, 2015 -
Who's on the list by Company
AbelsonTaylor Inc. Keith Stenlund Achillion Pharmaceuticals Kevin Kucharski Advanced Clinical LLC Leo Sheridan Alcobra Pharma David Baker Altasciences Chris Perkin AmerisourceBergen Corp. Marc Kikuchi Artcraft Health Marc Sirockman Astellas Pharma US Inc. Jim Robinson Astr...
By PharmaVoice Team • Aug. 1, 2015 -
Talent Pool
Pharma Pool Marcello Agosti Takeda Names Head of New Global Commercial Organization Takeda has named Marcello Agosti head of global commercial, based in Zurich. The company established the global commercial organization as part of its plans to structure operations to become more agile and custome...
By PharmaVoice Team • Aug. 1, 2015 -
Who's On The List by Section
Commanders & Chiefs Dr. Michelle Berrey Chimerix Rob Cosinuke athenahealth and Epocrates Jim Curtis Remedy Health Media Dr. Bruce Feinberg Cardinal Health Specialty Solutions Lisa Giles Giles & Associates Consultancy Inc. and Optivara Inc. Peter Goldschmidt Sandoz Inc. D...
By PharmaVoice Team • Aug. 1, 2015 -
Researchers & Scientists
Dr. Anish Suri Title: Senior Scientific Director, Discovery Immunology Company: Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson Education: Ph.D., Immunology, Washington University St. Louis; B.S., Biology, Angelo State University Famil...
By PharmaVoice Team • Aug. 1, 2015 -
Patient Advocates
Dr. Stella Blackburn Title: VP, Global Head of Risk Management, Real World & Late Phase Research Company: Quintiles Education: M.B., B.S., Medicine, Guy’s Hospital Med School, London University; M.Sc., Epidemiology, London School of Hygiene and Tropical Medicine, U. of London; M.A., Medical S...
By PharmaVoice Team • Aug. 1, 2015 -
Mentors
David Baker Title: Chief Commercial Officer Company: Alcobra Pharma Education: MBA, Duke University, Fuqua School of Business; B.A., Duke University Family: Wife, Irene; son, Adam, 22; daughter, Rachel, 18 Hobbies: Avid Philadelphia and Duke sports fan; restaurants; travel; sampling fine wine, wh...
By PharmaVoice Team • Aug. 1, 2015 -
Technologists
Tim Slevin Title: Senior VP, OpenData Global Company: Veeva Systems Education: MBA, BBA, University of Missouri-Kansas City Family: Wife, Susan; children, Ben and Grace; dog, Lucy Hobbies: Golfing, cycling Bucket List: Play golf at Pebble Beach with Huey Lewis; perform a three-minute stand-up co...
By PharmaVoice Team • Aug. 1, 2015 -
Fun Facts About the PharmaVOICE 100
Where they were born? The PharmaVOICE 100 may come from all over, but what they have in common is a sincere desire to improve the lives of patients everywhere. What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it t...
By PharmaVoice Team • Aug. 1, 2015 -
The Importance of Mentoring
Most of our PharmaVOICE 100 honorees say having and being a mentor are important for success in this industry. Here is what they say about the value of being a mentor to others. Sound Bites from the PharmaVOICE 100 Our honorees talk about the importance of mentoring. David Baker Chief Commercial ...
By PharmaVoice Team • Aug. 1, 2015 -
Overcoming the Challenges that Hinder Innovation
PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...
By PharmaVoice Team • Aug. 1, 2015 -
Innovation In a Patient-Centric World
From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...
By PharmaVoice Team • Aug. 1, 2015 -
Letter from the Editor
In the rare disease community there is saying: Alone we are rare, together we are strong. Wendy White, senior VP, for rare diseases, at Dohmen Life Science Services, a board member of Global Genes, and the president of the Heathcare Businesswomen’s Association (HBA), shared her personal rare dis...
By Taren Grom • June 1, 2015 -
2015 HBA Luminaries
The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...
By Taren Grom • May 1, 2015 -
Talent Pool
Biotechnology Pool Mary Thistle Dimension Names Chief Business Officer Dimension Therapeutics, a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, has appointed Mary Thistle to the newly created position of chief bu...
By PharmaVoice Team • April 1, 2015